A Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients

NCT01649388 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped study terminated by sponsor

Conditions

Kidney Transplantation

Interventions

BIOLOGICAL: FCR001

Sponsor

Talaris Therapeutics Inc.